Leadership is about driving change at scale and requires engaging both hearts and minds. Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, provides insights ...

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Two former Pfizer executives published a statement saying they support management as it gets pressured for changes by activist investor Starboard Value. The ex-Pfizer executives, Ian Read and ...

The program calls for 20 college juniors to be selected for a nine-year track to Pfizer leadership. ... Browse an unrivalled portfolio of real-time and historical market data and insights from ...

Pfizer is making these changes in preparation for integrating Seagen once the $43 billion merger closes, expected in late 2023 or early 2024. For now, the two companies are operating independently ...

WALTHAM, MASSACHUSETTS / ACCESS Newswire / February 4, 2025 / Data4Cure today announced an ongoing multi-year partnership with Pfizer, aimed at leveraging advanced analytics and knowledge graph AI ...

The lawsuit against Pfizer claimed its program violated laws including Section 1981 of the Civil Rights Act of 1866, which bars racial bias in contracting, and Title VI of the Civil Rights Act of ...